Due to this uncertainty, InCred is shifting its portfolio towards healthcare businesses with little or no US exposure. Previous Post IndusInd Bank shares in focus after clarification on PwC report Next Post Indian Pharma, Textile to Malaysian Glove Makers — The winners post Trump's reciprocal tariffs Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment